Your choices go into the PDF (cover and captions); this bar does not.
Rebalix
Comparison report · official data side by side

GERD vs K0MR


GERDL&G Gerd Kommer Multifactor Equity UCITS ETF
IE0001UQQ933 · Equity · Global · Multifattoriale
K0MRL&G Gerd Kommer Multifactor Equity UCITS ETF
IE000FPWSL69 · Equity · Global · Multifattoriale
Open the interactive comparison on rebalix.com →

Comparison window: 15 Jun 202331 Jul 2026 (max: from the most recent launch) · currency: 🇪🇺 EUR · inflation: 🇮🇹 Italy · distributions: reinvested where declared

Report produced on 10 September 2026 · data as of the dates shown per section
Sources: official issuer documents (KID, factsheet, declared NAV series and holdings), ESMA register, ECB rates, Eurostat
Public methodology: rebalix.com/en/methodology

Informational document generated by rebalix.com — facts side by side, no recommendations. It does not constitute investment advice or investment research under Directive 2014/65/EU (MiFID II). Past performance is not indicative of future results.

RebalixGERD vs K0MR · report of 10 September 2026

The funds at a glance

From official issuer documents and the ESMA register
GERDIE0001UQQ933L&G Gerd Kommer Multifactor Equity UCITS ETFEquity · Global · Multifattoriale
Declared index
Solactive Gerd Kommer Multifactor Equity Index NTR
TER
0.45%
Transaction (KID)
0.08%
Fund size
1.5 mld EUR
Launch
21 Jun 2023
Currency
USD
Replication
Physical (sampled)
Hedging
No
Holdings
0
Distributions 12m
acc.
Effective 🇮🇹 rate
K0MRIE000FPWSL69L&G Gerd Kommer Multifactor Equity UCITS ETFEquity · Global · Multifattoriale
Declared index
Solactive Gerd Kommer Multifactor Equity Index NTR
TER
0.45%
Transaction (KID)
0.08%
Fund size
1.5 mld EUR
Launch
21 Jun 2023
Currency
USD
Replication
Physical (sampled)
Hedging
No
Holdings
0
Distributions 12m
0.22 USD
Effective 🇮🇹 rate

Tracking difference — year by year

Fund minus index, from issuer-declared series (complete calendar years). Each measures adherence to its OWN index.
GERDn/d
2025
−0.28%
2024
−0.49%
K0MRn/d
2025
−0.28%
2024
−0.49%
Rebalix · GERD vs K0MRsection 1 of 3
RebalixGERD vs K0MR · report of 10 September 2026
GERDL&G Gerd Kommer Multifactor Equity UCITS ETF · IE0001UQQ933 · Equity · Global · Multifattoriale
K0MRL&G Gerd Kommer Multifactor Equity UCITS ETF · IE000FPWSL69 · Equity · Global · Multifattoriale

Performance over the period, in euro

From 15 Jun 2023 to 31 Jul 2026 · base 100 · ECB rates, dividends reinvested where declared
In euro (nominal)
10016195157157
In today’s purchasing power (net of Italy inflation)
10016195150150
GERDK0MR
Same scale in both panels: the gap between endpoints is Italian inflation over the period (Eurostat). Volatility stays nominal, as everywhere on the site.

How far they fell — drawdown from peak (nominal)

In euro · distance from the previous peak, day by day, on NAV: for distributing classes it includes ex-dividend drops (slightly deeper than total return)
0%-5%-10%-15%-20%GERDK0MR202420252026trough GERD: −18.2% · 07 Apr 2025trough K0MR: −18.4% · 07 Apr 2025
Filled area: GERD; thin lines: the other funds.
The worst episode, fund by fund
FundMax drawdownTroughRecovery timeUnderwater
GERD−18.2%07 Apr 2025177 days225 days · back to break-even on 01 Oct 2025
K0MR−18.4%07 Apr 2025182 days230 days · back to break-even on 06 Oct 2025
"Recovery time" = the climb only: trough to break-even (0%). "Underwater" = decline + recovery: peak to break-even.

Drawdown net of Italy inflation

Same curve in purchasing-power terms: as on the site, drawdown follows the real view (volatility stays nominal, per methodology)
0%-5%-10%-15%-20%GERDK0MR202420252026trough GERD: −19.8% · 07 Apr 2025trough K0MR: −20.0% · 07 Apr 2025
In real terms declines are deeper and recoveries slower. Monthly price index (Eurostat), held at the last published value.
Rebalix · GERD vs K0MRsection 2 of 3
RebalixGERD vs K0MR · report of 10 September 2026

Full comparison table

"—" = not published by the source, never estimated
GERDL&G Gerd Kommer Multifactor Equity UCITS ETF · IE0001UQQ933 · Equity · Global · Multifattoriale
K0MRL&G Gerd Kommer Multifactor Equity UCITS ETF · IE000FPWSL69 · Equity · Global · Multifattoriale
MetricGERDK0MRNote
Identity
CategoryEquity · Global · MultifattorialeEquity · Global · MultifattorialeRebalix engine classification
ReplicationPhysical (sampled)Physical (sampled)as declared by the issuer
Currency hedgingNoNosource: class name, factsheet
Income policyaccumulatingdistributing
Costs
TER0.45%0.45%from the KID
Transaction costs (KID)0.08%0.08%internal
All-in cost0.53%0.53%TER + transaction
Tracking difference (3a)vs its OWN index
Performance in euro (ECB rates)
1 year+22.3%+22.3%
3 years+54.1%+54.1%
5 years
10 years— = series younger than the window
Risk · last 3 years
Volatility (ann.)+11.48%+11.47%
Max drawdown−14.17%−14.35%
Sharpe1.341.20risk-free = ECB MRO avg
Sortino1.911.70like Sharpe, downside only
Distributions (fund currency)
Frequencyaccumulating classquarterly
Distributions, last 12 monthsaccumulating class0.22 USDper share
Distribution yieldaccumulating class1.32%12 months / NAV
Last ex-dateaccumulating class11 Jun 2026 · 0.0997 USD
Italian taxation
Effective capital-gains ratewhite list, current half-year
Documents & exchanges
Listing venues98ESMA register
Borsa Italiana tickerGERD
Indicative cumulative cost: on 10,000 euro over 5 years (stated assumption: 5%/yr growth, cost = TER + transaction) ~335 euro GERD · ~335 euro K0MR. Broker costs not included.

Disclaimer

This document is for information only and does not constitute investment advice under Directive 2014/65/EU (MiFID II), investment research, a personal recommendation, or an offer or solicitation to buy or sell financial instruments.

Past performance is not indicative of, nor a guarantee of, future results. The value of an investment can go down as well as up and investors may not get back the capital invested. Euro returns are affected by currency fluctuations.

Before any investment decision, read the KID and the Prospectus, available from the issuers. Tax treatment depends on individual circumstances and may change.

Data come from official issuer documents and public registers, following the public methodology at rebalix.com/en/methodology. "—" fields were not published by the source and have not been estimated. Rebalix receives no compensation from the issuers mentioned.

Rebalix · GERD vs K0MRsection 3 of 3